Literature DB >> 17639499

ID1-, ID2-, and ID3-regulated gene expression in E2A positive or negative prostate cancer cells.

Ananthi J Asirvatham1, Jason P W Carey, Jaideep Chaudhary.   

Abstract

BACKGROUND: The inhibitor of differentiation (Id) proteins are expressed in prostate cancer (PCA). However, there is a general lack of Id isoform-specific downstream effectors.
METHODS: Id1, Id2, or Id3 were silenced in PCA cell lines LNCaP, DU145, and PC3 using gene-specific small interfering RNA (siRNA). The effect of Id gene silencing on representative genes involved in apoptosis (p53, SNAIL2), proliferation (p21, p16), and tumor invasion (E-cadherin and MMP9) was investigated by real-time PCR. Expression of E-proteins, the primary Id interaction partners was also evaluated to understand the molecular mechanism of action.
RESULTS: The Id proteins regulated the expression of CDKNIs p16 and p21 even in the absence of E-proteins. Loss of Id1 and Id3 up- or downregulated E-cadherin expression in E-protein negative or positive PCA cell lines, respectively. The effect of Id genes on cell proliferation was also independent of CDKNIs in p16 and p21 null PC3 cells. The p53-independent anti-apoptotic effect of Id2 was mediated in part by transcriptional repressor SNAI2. MMP9 seems to be the common target of all three Id genes (Id1, Id2, and Id3).
CONCLUSIONS: The overall effect of Id proteins on proliferation and apoptosis is independent of E-proteins. E-proteins can however determine the magnitude of response or in some cases even reverse the Id-mediated target gene expression. Evaluating E-protein expression in conjunction with Id proteins will allow better understanding of the molecular mechanism of action of Id proteins and increase their prognostic significance in PCA. 2007 Wiley-Liss, Inc

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17639499     DOI: 10.1002/pros.20633

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  19 in total

1.  Therapeutic targeting of Id2 reduces growth of human colorectal carcinoma in the murine liver.

Authors:  M J Gray; N A Dallas; G Van Buren; L Xia; A D Yang; R J Somcio; P Gaur; L S Mangala; P E Vivas-Mejia; F Fan; A M Sanguino; G E Gallick; G Lopez-Berestein; A K Sood; L M Ellis
Journal:  Oncogene       Date:  2008-09-22       Impact factor: 9.867

2.  Id4 suppresses MMP2-mediated invasion of glioblastoma-derived cells by direct inactivation of Twist1 function.

Authors:  G J Rahme; M A Israel
Journal:  Oncogene       Date:  2014-01-13       Impact factor: 9.867

3.  ASBEL-TCF3 complex is required for the tumorigenicity of colorectal cancer cells.

Authors:  Kenzui Taniue; Akiko Kurimoto; Yasuko Takeda; Takeshi Nagashima; Mariko Okada-Hatakeyama; Yuki Katou; Katsuhiko Shirahige; Tetsu Akiyama
Journal:  Proc Natl Acad Sci U S A       Date:  2016-10-21       Impact factor: 11.205

4.  Large scale RNAi screen reveals that the inhibitor of DNA binding 2 (ID2) protein is repressed by p53 family member p63 and functions in human keratinocyte differentiation.

Authors:  Ning Wu; David Castel; Marie-Anne Debily; Maria Alessandra Vigano; Olivier Alibert; Roberto Mantovani; Kristina Iljin; Paul-Henri Romeo; Xavier Gidrol
Journal:  J Biol Chem       Date:  2011-04-10       Impact factor: 5.157

5.  Inhibitor of differentiation 1 (Id1) and Id3 proteins play different roles in TGFβ effects on cell proliferation and migration in prostate cancer cells.

Authors:  Nicole Strong; Ana C Millena; Lindsey Walker; Jaideep Chaudhary; Shafiq A Khan
Journal:  Prostate       Date:  2012-10-11       Impact factor: 4.104

6.  Id2, Id3 and Id4 overcome a Smad7-mediated block in tumorigenesis, generating TGF-β-independent melanoma.

Authors:  Kyle A DiVito; Cynthia M Simbulan-Rosenthal; You-Shin Chen; Valerie A Trabosh; Dean S Rosenthal
Journal:  Carcinogenesis       Date:  2013-12-16       Impact factor: 4.944

7.  Increased expression of bHLH transcription factor E2A (TCF3) in prostate cancer promotes proliferation and confers resistance to doxorubicin induced apoptosis.

Authors:  Divya Patel; Jaideep Chaudhary
Journal:  Biochem Biophys Res Commun       Date:  2012-04-30       Impact factor: 3.575

8.  E47 and Id1 interplay in epithelial-mesenchymal transition.

Authors:  Eva Cubillo; Antonio Diaz-Lopez; Eva P Cuevas; Gema Moreno-Bueno; Hector Peinado; Amalia Montes; Vanesa Santos; Francisco Portillo; Amparo Cano
Journal:  PLoS One       Date:  2013-03-26       Impact factor: 3.240

9.  Targeting Id1 reduces proliferation and invasion in aggressive human salivary gland cancer cells.

Authors:  Tomoki Sumida; Ryuichi Murase; Akiko Onishi-Ishikawa; Sean D McAllister; Hiroyuki Hamakawa; Pierre-Yves Desprez
Journal:  BMC Cancer       Date:  2013-03-22       Impact factor: 4.430

10.  Id1 and Id3 expression is associated with increasing grade of prostate cancer: Id3 preferentially regulates CDKN1B.

Authors:  Pankaj Sharma; Divya Patel; Jaideep Chaudhary
Journal:  Cancer Med       Date:  2012-08-28       Impact factor: 4.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.